Answered You can hire a professional tutor to get the answer.
Imagine that you belong to a group of scientists in a biotech company who are evaluating the potential of several therapies for the most common...
A. small chemical, administered as a pill that is a strong inhibitor of protein degradation.
Your evaluation:
Does the therapy treat the underlying molecular defect?
Is the method of delivery of the therapy reasonable: is the therapy likely to reach the affected tissues?
Is the therapy likely to have significant side effects? Explain.
Suggest at least one improvement to this therapy.
An antibody, administered as a pill that binds to the extracellular part of CFTR and changes its conformation, making it more likely to be open.
Your evaluation:
Does the therapy treat the underlying molecular defect?
Is the method of delivery of the therapy reasonable: is the therapy likely to reach the affected tissues?
Is the therapy likely to have significant side effects? Explain.
Suggest at two improvements to this therapy.
